Back to dashboard
All PlansCoverageMedium impact

Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation

Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This is a comprehensive medical policy detailing coverage criteria for percutaneous left atrial appendage closure (LAAC) devices like Watchman and Amplatzer Amulet for stroke prevention in atrial fibrillation patients. The policy appears to be establishing or updating coverage guidelines for these specialized cardiac procedures.

Action Required

Action needed
Immediately: Review complete policy document to identify specific coverage criteria, prior authorization requirements, and billing guidelines for LAAC procedures. Contact medical policy department to obtain full policy text including coverage determination criteria and required documentation. Ensure cardiology billing staff are aware of FDA-approved devices (Watchman, Watchman FLX, Amplatzer Amulet) versus non-approved devices for proper claims processing.

Related policy hubs